#Business #WallStreet
The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug results look more promising.
WSJ.com: US Business
PAID
This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.